AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Net Income (TTM): -14.05M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -14.05M |
| June 30, 2023 | -11.08M |
| March 31, 2023 | -11.03M |
| December 31, 2022 | -10.46M |
| September 30, 2022 | -9.917M |
| June 30, 2022 | -9.437M |
| March 31, 2022 | -9.293M |
| December 31, 2021 | -8.675M |
| September 30, 2021 | -8.963M |
| June 30, 2021 | -9.551M |
| Date | Value |
|---|---|
| March 31, 2021 | -9.766M |
| December 31, 2020 | -10.86M |
| September 30, 2020 | -11.13M |
| June 30, 2020 | -11.81M |
| March 31, 2020 | -12.21M |
| December 31, 2019 | -12.15M |
| September 30, 2019 | -12.63M |
| June 30, 2019 | -11.56M |
| March 31, 2019 | -10.40M |
| December 31, 2018 | -7.502M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-14.05M
Minimum
Sep 2023
-8.675M
Maximum
Dec 2021
-10.81M
Average
-10.95M
Median
Net Income (TTM) Benchmarks
| Homology Medicines Inc (DELISTED) | -112.96M |
| NovaBay Pharmaceuticals Inc | -11.12M |
| Palatin Technologies Inc | -35.49M |
| iBio Inc | -23.16M |
| Theriva Biologics Inc | -19.04M |